Report Highlights
-
The global spinal surgical market is projected to reach almost $6.5 billion by 2015, a 3.4% compound annual growth rate (CAGR) over the 2010 value of $5.5 billion.
-
The nonfusion device segment is expected to grow at a 10% compound annual growth rate (CAGR) versus 1.3% for fusion products, but it is not expected to constitute more than 15% of the total spinal surgical device market by 2015. This sector is valued at $624 million in 2010 and is expected to reach $1 billion by 2015.
-
Vertebral repair is a rapidly growing market, directly related to the continued growth of the aging population and osteoporosis-related fractures. This sector is valued at $532 million in 2010 and is expected to increase at a 10% compound annual growth rate (CAGR) to reach $858 million in 2015.
INTRODUCTIONn
- Assess the prevalence of common spinal conditions and trends affecting their projected future incidence
- Examine current procedure volumes and associated expenditures, as well as projected increases in demand by technique
- Analyze the current market and forecast demand for implantable spinal surgical devices
- Describe the regulatory framework and its effect on the introduction of new devices into the spinal market both in the U.S. and abroad
- Analyze trends in patent applications and issued patents for innovations that will be altering the spinal marketplace
- Examine the drivers that will affect future utilization and rate of adoption of the implants, including demographic changes, reimbursement policy, clinical considerations, and R&D
- Identify the product manufacturers that will drive innovation, their market share, and other industry players
- The worldwide growth of the senior population will strain the capabilities of healthcare providers and the financial resources of healthcare payers.
- Patients are increasingly less likely to accept “aging pains” as they wish to maintain a more active lifestyle even with advancing age.
- Obesity, which is also increasing globally, will similarly contribute to higher rates of back pain and degenerative conditions.
- Advances in biologics, materials, imaging techniques, and the biomechanical understanding of the spine will enable treatment of spinal conditions with a focus on preservation of natural range of motion.
- To contain costs while simultaneously facing an increased procedural volume, focus is shifting toward improving instruments and techniques to reduce the invasiveness of surgery, thereby shortening hospital stays and hastening recovery.
- Increased focus is being placed on the cost benefit of surgical procedures and implants.
- Current prevalence of common spinal problems, trend analysis, and factors influencing future incidence
- Market analysis by surgical procedure, including annual incidence, trend analysis, and factors influencing future predicted surgical volume
- Global demand by device and projected future trends by device category
- Risk factors and other drivers that will affect the future incidence of spine surgery and related utilization of spinal surgical devices
- U.S. and international regulation of spinal devices
- Patent analysis
- Market share and information on key device manufacturers
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers
Related Reports
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More